InsidersTradesSigma
Track the 티움바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 티움바이오 has published 13 public disclosures. The latest transaction was reported on 22 April 2022 (Sale). Among the most active insiders: 김훈택. The full history is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 April 2022
Declarations13 total
2,574,623 sharesKRXDART:20220422000656
2,574,623 sharesKRXDART:20211224000476
2,574,623 sharesKRXDART:20211130002070
2,574,623 sharesKRXDART:20210402000323
13 of 13 declarations
关于 티움바이오
Tium Bio是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发创新的治疗方法和治疗解决方案。